The Tunisian ANMPS has published a new questionnaire addressed to Marketing Authorization Holders (MAHs) as part of the ongoing strengthening of Pharmacovigilance and regulatory compliance activities in Tunisia. This initiative further highlights the importance of maintaining robust local PV oversight and effective regulatory support through qualified local partners.
These two questionnaires were developed to collect accurate and relevant information to guide future actions, improve current practices, and strengthen the effectiveness of the pharmacovigilance system in Tunisia. Participation is essential, as each response will contribute to informed decision-making and the development of future strategies. All information collected will remain strictly confidential and will be used solely for academic purposes and continuous improvement. The submission deadline is 30 June 2026.
Questionnaires:
- Questionnaire: Implementation of Pharmacovigilance (PV) systems in pharmaceutical industries in Tunisia – Challenges and key issues: https://lnkd.in/dunhQ7QW
- Questionnaire: QPPV/LSR Nomination: https://lnkd.in/dqbSehuX
AREMA supports pharmaceutical companies with Local Safety Representative (LSR/LCPPV) services, Pharmacovigilance activities, and Regulatory Affairs support in Tunisia and across the region.